The First Selective 5-HT7 Receptor Antagonist - ACS Publications

J Ogilvie , M Wigglesworth , L Appleby , T O W Kingston , R W Clarke ... Graham Riley , Jim Hagan , Israel Gloger , Catherine E. Ellis , Ian T. Forbes...
0 downloads 0 Views 70KB Size
© Copyright 1998 by the American Chemical Society

Volume 41, Number 5

February 26, 1998

Communications to the Editor (R)-3,N-Dimethyl-N-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzenesulfonamide: The First Selective 5-HT7 Receptor Antagonist Ian T. Forbes,*,† Steven Dabbs,† D. Malcolm Duckworth,† Andrew J. Jennings,† Frank D. King,† Peter J. Lovell,† Anthony M. Brown,‡ Lissa Collin,‡ Jim J. Hagan,‡ Derek N. Middlemiss,‡ Graham J. Riley,‡ David R. Thomas,‡ and Neil Upton‡ SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, England, CM19 5AW Received August 4, 1997

The 5-HT7 receptor is the most recent addition to the burgeoning family of 5-HT receptors.1 5-HT7 receptors have been cloned from rat,2-4 mouse,5 guinea pig,6 and human7 cDNA and exhibit a high degree of interspecies homology (approximately 95%) but a low sequence homology with other 5-HT receptors (